Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 18
Figure 4. Europe Biopharmaceuticals Market, 2023-2033, $ mn 21
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of Europe Biopharmaceuticals Market 31
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 34
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 34
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 35
Figure 10. Primary Restraints and Impact Factors of Europe Biopharmaceuticals Market 40
Figure 11. Investment Opportunity Analysis 44
Figure 12. Porter’s Fiver Forces Analysis of Europe Biopharmaceuticals Market 47
Figure 13. Breakdown of Europe Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 52
Figure 14. Europe Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 52
Figure 15. Europe Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 53
Figure 16. Europe Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 54
Figure 17. Europe Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 18. Europe Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 19. Europe Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 57
Figure 20. Europe Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 58
Figure 21. Europe Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 59
Figure 22. Europe Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 60
Figure 23. Europe Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 61
Figure 24. Europe Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 62
Figure 25. Europe Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 63
Figure 26. Europe Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 64
Figure 27. Europe Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 65
Figure 28. Europe Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 66
Figure 29. Europe Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 67
Figure 30. Europe Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 68
Figure 31. Europe Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 69
Figure 32. Europe Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 70
Figure 33. Europe Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 71
Figure 34. Europe Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 73
Figure 35. Europe Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 74
Figure 36. Europe Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 75
Figure 37. Europe Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 76
Figure 38. Europe Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 78
Figure 39. Europe Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 79
Figure 40. Europe Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 80
Figure 41. Europe Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 81
Figure 42. Europe Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 82
Figure 43. Europe Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 83
Figure 44. Europe Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 84
Figure 45. Europe Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 85
Figure 46. Europe Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 86
Figure 47. Europe Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 87
Figure 48. Europe Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 88
Figure 49. Europe Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 89
Figure 50. Europe Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 90
Figure 51. Europe Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 91
Figure 52. Breakdown of Europe Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 93
Figure 53. Europe Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 93
Figure 54. Europe Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 94
Figure 55. Europe Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 95
Figure 56. Europe Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 96
Figure 57. Breakdown of Europe Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 98
Figure 58. Europe Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 98
Figure 59. Europe Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 99
Figure 60. Europe Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 100
Figure 61. Europe Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 101
Figure 62. Breakdown of Europe Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 103
Figure 63. Europe Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 103
Figure 64. Europe Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 104
Figure 65. Europe Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 105
Figure 66. Breakdown of Europe Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 107
Figure 67. Europe Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 107
Figure 68. Europe Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 108
Figure 69. Europe Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 109
Figure 70. Europe Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 110
Figure 71. Europe Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 111
Figure 72. Europe Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 112
Figure 73. Europe Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 113
Figure 74. Europe Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 114
Figure 75. Europe Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 115
Figure 76. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 117
Figure 77. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 118
Figure 78. Biopharmaceuticals Market in Germany, 2023-2033, $ mn 119
Figure 79. Biopharmaceuticals Market in U.K., 2023-2033, $ mn 121
Figure 80. Biopharmaceuticals Market in France, 2023-2033, $ mn 123
Figure 81. Biopharmaceuticals Market in Spain, 2023-2033, $ mn 125
Figure 82. Biopharmaceuticals Market in Italy, 2023-2033, $ mn 127
Figure 83. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn 129
Figure 84. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn 131
Figure 85. Growth Stage of Europe Biopharmaceuticals Industry over the Forecast Period 133
Figure 86. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 135